Stamford, CT -- (SBWIRE) -- 01/10/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Geron Corporation (NASDAQ:GERN), Arrowhead Research Corp (NASDAQ:ARWR), Sequenom, Inc. (NASDAQ:SQNM), Barnes & Noble, Inc. (NYSE:BKS).
Geron Corporation (NASDAQ:GERN) opened its last trade at the price of $4.99. Its closing price was $5.23 after gaining 8.28% for the day. The company traded with the total volume of 7.01 million shares, while its average trading volume remained 5.40 million shares. The beta of this stock stands at 1.24. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
For How Long GERN will Fight for Profitability? Read This Trend Analysis report
Arrowhead Research Corp (NASDAQ:ARWR) percentage change surged 7.78% to close at $11.50 with the total traded volume of 1.67 million shares, along with average volume of 648,202.00 shares. The 52 week range of the stock remained $1.65 - $11.57, while its day lowest price was $10.82. The share price hit the day highest price of $11.57. Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and Adipotide.
For How Long ARWR’s Gloss will Attract Investors? Find out via this report
Sequenom, Inc. (NASDAQ:SQNM) traded on volume of 7.89 million shares in the last session against average volume of 1.69 million shares. The company started its trading session with the price of $2.70 and closed at $2.64 by scoring +7.32%. Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis. The Molecular Diagnostics segment researches, develops, and commercializes various noninvasive molecular diagnostic tests for prenatal genetic disorders and diseases; women’s health related disorders and diseases.
Will SQNM Continue To Move Higher? Find Out Here
Barnes & Noble, Inc. (NYSE:BKS) started its last trading session with the price of $14.67 and closed at $15.67 by scoring 7.11%. The stock traded with total volume of 2.87 million shares, while the average trading volume remained 1.68 million shares. The beta value of this stock stands at 0.92. Day range for the stock was $14.63 - $15.73. Barnes & Noble, Inc. operates as a content, commerce, and technology company in the United States. The company operates in three segments: B&N Retail, B&N College, and NOOK. It provides access to books, magazines, newspapers, and other content through its multi-channel distribution platform.
Why Should Investors Buy BKS After The Recent Gain? Just Go Here and Find Out
About Wall Street Pennies
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, http://www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)